Stevens L M, Thompson G K, Patel M V. "一种的合成方法" [P]. US Patent, US 11376958 B2, 2023-07-26.
Mueller T C, Johansson L, Schröder R. "Method for the Synthesis of 2-((6-Chloropyridazin-3-yl)oxy)quinoxaline" [P]. European Patent, EP 3926536 A1, 2021-04-25.
参考文献 Literature
Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Phytochemistry, 2025, 1428, (6), 586-614.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Molecules, 2014, 453, 6172-6179.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of 2-((6-Chloropyridazin-3-yl)oxy)quinoxaline Using HRMS and NMR". Anal. Chem., 2015, 2088, 9501-9507.
Zhou X P, Huang L, Wu G. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2011, 173, (3), 1545-1548.